Clinical Research Directory
Browse clinical research sites, groups, and studies.
Adjunctive Gypenosides for Acute Optic Neuritis
Sponsor: First Affiliated Hospital of Guangxi Medical University
Summary
This pilot randomized, double-blind, placebo-controlled trial evaluated whether short-course adjunctive gypenosides, added to standard corticosteroid treatment, may preserve retinal structural outcomes in adults with acute optic neuritis.
Official title: Adjunctive Gypenosides for Acute Optic Neuritis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2017-02-04
Completion Date
2018-07-30
Last Updated
2026-05-20
Healthy Volunteers
No
Conditions
Interventions
Gypenosides
Participants received gypenosides 180 mg/day, given as 60 mg three times daily for 10 days, started on the first day of intravenous methylprednisolone. All participants also received standard corticosteroid treatment.
Placebo
Participants received matching placebo capsules three times daily for 10 days, started on the first day of intravenous methylprednisolone. All participants also received standard corticosteroid treatment.
Locations (1)
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China